SOTA 01: Global Strategies to Improve Deceased Organ Donation
Chairs: Guenter Kirste, Germany & Raimund Margreiter, Austria

• Strategic Donation Initiatives through DOPKI and the WHO - Beatriz Dominguez Gil, Spain
• Improvement in Organ Donation in Australia - Gerry O'Callaghan, Australia
• Improving Organ Donation in Brasil and Latin America - Eduardo Rocha, Brazil
• Increasing Utilization of Deceased Donor Kidneys - Kevin O'Connor, USA

SOTA 02: Hematopoietic Stem Cell Transplantation
Chairs: Wing Au, Hong Kong & Michael Barnett, Canada

• Genetic Networks in Stem Cell Biology and Function - Guy Sauvageau, Canada
• Hematopoeitic Stem Self Renewal, Differentiation and Cord Blood Transplantation - Clayton Smith, Canada
• Innovations in Stem Cell Expansion and Transplantation - Joachim Deeg, USA

SOTA 03: Induction Immunosuppression
Chairs: Gabriel Danovitch, USA & Denis Glotz, France

• New Molecular Targets for Biological Therapy - Flavio Vincenti, USA
• Immunological Consequences of Different Induction Strategies - Nader Najafian, USA
• Induction Therapy in Renal Transplant Patients - Daniel Abramowicz, Belgium
• Induction Therapy in Non-Renal Transplant Patients - Lionel Rostaing, France

SOTA 04: Allorecognition and Response
Chairs: Terry Strom, USA & Anthony Jevnikar, Canada

• Complementary Roles of Innate and Adaptive Immunity - Fadi Lakkis, USA
• B Cell Selection and Anergy in Humans - Patrick Wilson, USA
• B Cells in Rejection and Tolerance - Anita Chong, USA

SOTA 05: Antibody-Mediated Rejection (AMR). The Changing Face of Rejection in Heart Transplantation
Chairs: Mario Deng, USA & Stephan Schueler, Denmark

• Pretransplant Sensitization - Jon Kobashigawa, USA
• Clinical Spectrum/Presentation of AMR - Abdallah Kfoury, USA
• Current Therapies for AMR - Andreas Zuckermann, Austria

SOTA 06: Living Donor Liver Transplantation
Chairs: Roy Calne, UK & Peter Neuhaus, Germany

• Right and Left Grafts and the Small-For-Size Syndrome - Chung Mau Lo, Hong Kong
• Recipient Outcomes in the A2ALL Study - Abraham Shaked, USA
• Analysis of Worldwide Donor Morbidity and Mortality - David Grant, Canada

SOTA 07: Islet Transplantation: Immunology and Physiology
Chairs: David Sutherland, USA & Camillo Ricordi, USA

• Significance of Autoimmunity in Clinical Islet Transplantation - Ron Gill, Canada
• Significance of Alloimmunity in Clinical Islet Transplantation - Bart Roep, The Netherlands
• Results and Clinical Impact of Islet Autotransplantation: Lessons for Islet Allo-Transplantation - David Sutherland, USA
• Impact on Hypoglycemia and Metabolic Effect on Glucose/Insulin/Counter-Regulation - Michael Rickels, USA

SOTA 08: Principles and Practice of Living Donor Exchange
Chairs: Lloyd Ratner, USA & John Gill, Canada

• Living Donor Exchange for Sensitized Patients - Dorry Segev, USA
• The National Living Donor Exchange Programme in The Netherlands - Marry de Klerk, The Netherlands
• How to Organize a National Living Donor Exchange Program - Ed Cole, Canada

SOTA 09: Biology and Therapeutic Potential of Regulatory Cells
Chairs: Shuiping Jiang, China & Angus Thomson, USA

• Signaling Pathways in Regulatory Cells - Megan Levings, Canada
• T-Regulatory Cells: Phenotype and Function - Alexander Rudensky, USA
• Regulatory B Cells - Tom Tedder, USA

SOTA 10: Maintenance Immunosuppression
Chairs: Benedict Cosimi, USA & Bernard Charpentier, France

• Novel Approaches to Inhibit Intracellular Signals - Barry Kahan, USA
• Concentration-Controlled Immunosuppressions - Teunis van Gelder, The Netherlands
• Translational Research and Maintenance Immunosuppression - Allan Kirk, USA
• Strategies in Transplant Patients with Chronic Kidney Disease - Marcelo Cantarovich, Canada

SOTA 11: Transplant Genomics and Biomarkers of Injury
Chairs: Andrew Bradley, UK & Roslyn Mannon, USA

• Transplantomics: Report of the First International Meeting - Minnie Sarwal, USA
• Integrative Genomics in Organ Transplantation - Dan Salomon, USA
• Genetic and Molecular Mechanisms in Chronic Allograft Injury - Phil Halloran, Canada

SOTA 12: Biological Function and Clinical Relevance of Antibodies to Transplantation Antigens
Chairs: Paul Terasaki, USA & Howard Gebel, USA

• Determinants of Biological Function of Anti-Donor Antibodies - Elaine Reed, USA
• Comparative Clinical Importance of Class I and Class II Antibodies - Samantha Fidler, Australia
• Clinical Relevance of Antibodies to Non-HLA Antigens - Duska Dragun, Germany
• The Role and Future of the Flow and Cytotoxic Crossmatch - Ron Kerman, USA

SOTA 13: Liver Transplantation For Hepatocellular Cancer
Chairs: Federico Villamil, Brazil & Bill Wall, Canada

• Tumor Selection Criteria - A New Approach - Norman Kneteman, Canada
• Locoregional Therapy Pre-Transplant - Francis Yao, USA
• Priority of HCC Candidates on the Waiting List - Rich Freeman, USA

SOTA 14: Islet Cell Replacement: Outcomes and Allocation
Chairs: Anthony Monaco, USA & Phil O'Connell, Australia

• Results of Pancreas Transplantation in 2010. The Case for Prioritized Allocation to Whole Pancreas. - James Shapiro, Canada
• Results of Pancreas Transplantation in 2010. The Case for Prioritized Allocation to Islet Transplantation. - Stephen Bartlett, USA
• Impact of Pancreas and Islet Transplantation on Secondary Complications - Antonio Secchi, Italy
• Synthesizing the Data. Synthesizing the Evidence: A Strategy for Allocation to Pancreas and Islet Transplantation. - Paul Johnson, UK
  

SOTA 15: Developing Societal and Ethical Consensus on Living Donation
Chairs: Howard M. Nathan, USA & Anwar Naqvi, Pakistan

• The Istanbul Declaration and Beyond - Francis Delmonico, USA
• The Position of the WHO on Living Donation - Luc Noel, Switzerland
• Aspects of Organ Donation in the Muslim Society - Farhat Moazam, Pakistan
• Overcoming the Problem of Commercialism in India - Georgi Abraham, India

SOTA 16: Innovations in Regenerative Medicine
Chairs: Alan Colman, Singapore & Doris Taylor, USA

• Stem Cells and Gene Transfer in Transplantation and Regeneration - Hans-Dieter Volk, Germany
• Tissue Engineering for Transplantation and Regenerative Medicine - Michael Sefton, Canada
• Regenerative Medicine and the Stem Cell: A Marriage That Is Improving with time - Alan Colman, Singapore

SOTA 17: Prevention and Treatment of Antibody Mediated Rejection
Chairs: Ulrich Frei, Germany & Carl Cardella, Canada

• Factors influencing Tolerance and Outcome in ABO Incompatible Transplantation - Gunnar Tyden, Sweden
• A Critical Review of the Transplantation Response in the Pre-Sensitized Patient - Alice Peng, USA
• Acute Antibody-Mediated Rejection - Millie Samaniego, USA
• Chronic Antibody-Mediated Rejection - Mark Stegall, USA

SOTA 18: Immune Regulation and Tolerance
Chairs: Peter Morris, UK & Anita Chong, USA

• Mechanisms of Immune Regulation and Tolerance - Mohamed Sayegh, USA
• Mixed Chimerism and Human Tolerance - Megan Sykes, USA
• Molecular Signatures of Human Tolerance - Jean-Paul Soulillou, France

SOTA 19: Clinically Relevant Molecular Mechanisms in Lung Transplantation
Chairs: Shaf Keshavjee, Canada & Marty Zamora, USA

• Recipient and Donor Characteristics Associated with Primary Graft Dysfunction - Jason Christie, USA
• Fibrosis Rather Than Alloreactivity is the Target in Chronic Lung Allograft Dysfunction - Annette Boehler, Switzerland
• Donor Specific Antibodies Post Lung Transplant - Making Sense of the Data - Adriana Zeevi, USA
• Targeted Therapy for Severe Pulmonary Arterial Hypertension in Idiopathic Pulmonary Fibrosis - Paul Corris, UK

SOTA 20: Hepatitis C Positive Patient
Chairs: Gary Levy, Canada & Olaf Guckelberger, Germany

• Risk Factors for HCV Recurrence - Marina Berenguer, Spain
• Immunosuppression for the HCV Recipient - Gary Levy, Canada
• The Treatment of HCV Recurrence - Mike Charlton, USA

SOTA 21: Ischemia - Reperfusion Injury
Chairs: Hans Sollinger, USA & Ferdinand Muehlbacher, Austria

• The Biology of Brain Death and Organ Damage- Stefan Tullius, USA
• Tissue Inflammation and Repari - Joe Bonventre, USA
• Strategies for Cytoprotection in Ischemic Organ Injury - Pierre Clavien, Switzerland
• Current Status of Organ Preservation Solutions - Thomas van Gulik, The Netherlands

SOTA 22: Planning for Donation After Cardiac Death
Chairs: Ron Shapiro, USA & Sam Shemie, Canada

• Uncontrolled Donation After Cardiac Death - Jose Nunez, Spain
• Donation After Cardiac Death in the US - Howard M. Nathan, USA
• Development of UK DCD Program from Legal and Medical Perspectives - Chris Rudge, UK
• Optimal Preservation of NHB-Donor Grafts - Rutger Ploeg, The Netherlands

SOTA 23: Tissue Transplantation and Reconstruction
Chairs: Stefan Tullius, USA & Mark Hardy, USA

• Adapting the Banff Scoring System to the Biology of Vacularized Composite Allografts - Linda Cendales, USA
• Mixed Tissue Transplantation for Facial Reconstruction - Maria Siemionow, USA
• Mixed Tissue Transplantation for Limb Replacement - Max Dubernard, France

SOTA 24: Immunosuppression and Post-Transplant Malignancy
Chairs: Angela Webster, Australia & Peter Metrakos, Canada

• Molecular Signals, Viral Infection and Immune Suppression in Post-Transplant Malignancy - Edward Geissler, Germany
• Epidemiology of Malignancy After Transplantation - Gerhard Opelz, Germany
• Immunosuppressive Strategeis in Patients with Post-Transplant Malignancy - Ryutaro Hirose, USA
• Innovations in Therapy of Cancer in Transplant Recipients - J. Connor, Canada

SOTA 25: Injury, Repair and Remodeling
Chairs: Bruce McManus, Canada & Jerzy Kupiec-Weglinski, USA

• Innate and Adaptive Immunity in Ischemia-Reperfusion Injury - Jerzy Kupiec-Weglinski, USA
• Biomarkers of Injury and Response in Transplanted Patients - Bruce McManus, Canada
• Genomic Fingerprints of Tissue Injury and Remodeling / Role of the Endothelium - Marie Jose Hebert, Canada

SOTA 26: Cellular Xenotransplantation
Chairs: Richard Pierson, USA & Jean Tchervenko, Canada

• Anti-Gal and Non-Gal Antibodies in Xenotransplantation - Michael Breimer, Sweden
• Developments in Cellular Xenotransplantation - Emanuele Cozzi, Italy
• Islet Xenotransplantation: Advances towards the Clinic - Bernhard Hering, USA

SOTA 27: Graft Injury in Liver Transplantation
Chairs: Rui Maio, Portugal & Steve Lynch, Australia

• Clinical Prevention of Ischemi-Reperfusion Injury - Ron Busuttil, USA
• DCD Grafts - Nigel Heaton, UK
• Steatotic Grafts - John Fung, USA

SOTA 28: Intestinal Transplantation
Chairs: Andreas Tzakis, USA & David Grant, Canada

• Basic Science of Intestinal Transplantation - Michael Zasloff, USA
• Intestine Rehabilitation Options - Loris Pironi, Italy
• ITR and SRTR Clinical Outcomes - George Mazariegos, USA